Last reviewed · How we verify
NCT06800456
The Role of Cyberchondria Severity in the Relationship Between HPV Awareness and Vaccination Attitudes in Adult Women
trial in Human Papillomavirus Infection in 337 participants. Completed in 1 December 2024.
1 December 2024
Quick facts
| Lead sponsor | Acibadem University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 337 |
| Start date | 1 June 2024 |
| Primary completion | 1 December 2024 |
| Estimated completion | 1 December 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Human Papillomavirus Infection — all drugs for Human Papillomavirus Infection →
- HPV Vaccines — all drugs for HPV Vaccines →
- Cyberchondria — all drugs for Cyberchondria →
- Awareness — all drugs for Awareness →
Sponsor
Acibadem University
Who can join
Adults 18 to 49, female only, with Human Papillomavirus Infection or HPV Vaccines. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Human papillomavirus (HPV) is a prevalent sexually transmitted infection linked to nearly all cases (99%) of cervical cancer. Prophylactic HPV vaccination is effective in preventing these cancers, complemented by HPV screening and treatment of precancerous lesions. The World Health Organization (WHO) aims to eliminate cervical cancer by 2030 through focused efforts on vaccination, diagnosis, and treatment. Primary prevention strategies include reducing sexual risk factors and administering prophylactic vaccines. Despite awareness of HPV testing, many women lack understanding of its importance and fail to follow through with screenings and necessary treatments. Overall societal awareness of HPV remains inadequate. Studies reveal disparities in HPV vaccine awareness: while 60.7% of women have heard of the vaccine, only 1% have received it. Awareness varies widely across regions, with Turkey reporting rates from 3.8% to 57%, and vaccine awareness ranging from 2.2% to 74.7% (Özdemir et al., 2020). In the UK, concerns over potential negative results lead many women to defer HPV testing. Health anxiety, defined as interpreting minor symptoms as serious health issues, drives individuals to seek excessive online health information, a phenomenon known as cyberchondria. Studies link cyberchondria with heightened health anxiety, exacerbated by prolonged internet searches. Barriers to HPV screening and vaccination include fear of side effects, lack of information, cost concerns, and anxiety over potential outcomes. While women testing positive for HPV show higher levels of cyberchondria, no direct correlation has been established between cyberchondria severity and HPV awareness or vaccination attitudes in adult women. This summary encapsulates the key findings and insights from the referenced studies on HPV, vaccination, and health anxiety.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Role of cyberchondria severity in the relationship between HPV awareness and vaccination status among adult women.
Coşkun M, Ünlü Suvari G, Özdemir İN. · · 2025 · PMID 41408614 · DOI 10.1186/s12889-025-25938-5
Verify or expand the search:
- PubMed search for NCT06800456
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Human Papillomavirus Infection
Currently open trials in the same condition.
- NCT07281430 — Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04) · NA · recruiting
- NCT06598475 — Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve · NA · recruiting
- NCT06611553 — Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02) · NA · active not recruiting
- NCT06611540 — Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03) · NA · active not recruiting
- NCT06498661 — Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01) · NA · recruiting
Other Acibadem University trials
Trials by the same sponsor.
- NCT07481864 — The Effect of Early-Phase Graded Motor Imagery Following Massive Rotator Cuff Repair. · NA · not yet recruiting
- NCT07488377 — Turkish Cognitive Self-Efficacy Questionnaire in Parkinson's Disease · not yet recruiting
- NCT07488364 — Determinants of Physical Frailty in Parkinson's Disease: A Multi-Factorial Analysis · not yet recruiting
- NCT07488351 — "Self-Compassion and Self-Efficacy in Parkinson's Disease: Associations With Symptoms, Function, and Quality of Life" · not yet recruiting
- NCT07413185 — Relationship Between the Severity of Sleep Deprivation in the First 48 Hours Postpartum, Breastfeeding Motivation, and B · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06800456 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Acibadem University
- Last refreshed: 30 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06800456.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing